100s of titles, one news app for just $10 a month.
Dive Deeper:
Preview: Precision BioSciences's Earnings
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Meridian Bioscience's Earnings: A Preview
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to…
Earnings Outlook For Selecta Biosciences
Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
Earnings Outlook For Coherus BioSciences
Coherus BioSciences (NASDAQ:CHRS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Aterian's Earnings Outlook
Aterian (NASDAQ:ATER) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know…
Earnings Outlook For Kaleyra
Kaleyra (AMEX:KLR) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know…
Get all your news in one place
Latest Business news:
Jeff Bezos Lashes Out at Joe Biden and The Democrats
Amazon founder had previously avoided public tussles with the federal government.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Renault hands Russian assets to Moscow
Moscow (AFP) - French automaker Renault has handed over its Russian assets to the Russian government, both parties announced Monday,…
National Carrier to Be Privatized, PM Says: Sri Lanka Latest
Debt-ridden Sri Lanka will privatize its state-run national carrier, Sri Lankan Airlines, Prime Minister Ranil Wickremesinghe said in a televised…
Bitcoin recovers above $30,000, other crypto prices today also surge; Terra cracks 31%
Cryptocurrency Bitcoin staged a modest recovery and was up more than 2%
Elon Musk Takes a Stand in Controversial Disney Copyright Case
The copyright debate has recently been revived by a bill seeking to reduce the term of protection for original works.
From analysis to good news, read the world’s best news in one place
Facebook changing with times a decade after stock debut
San Francisco (AFP) - Facebook boss Mark Zuckerberg rang the opening bell remotely to cheers 10 years ago as the…
WA craft brewer Boston Brewery creates wet hop beers to help sustain farms
WA craft brewers are experimenting with wet hop beers that can only be made using freshly harvested, local hops. It…

Arcus Biosciences's Earnings Outlook

By Benzinga Insights

Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement.

Analysts estimate that Arcus Biosciences will report an earnings per share (EPS) of $-0.31.

Arcus Biosciences bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $4.45, which was followed by a 18.59% increase in the share price the next day.

Here's a look at Arcus Biosciences's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.74 -1.08 -0.88 -0.84
EPS Actual 3.71 -1.11 -1.09 -1.08
Price Change % 18.59% 11.97% -10.56% -2.62%

Stock Performance

Shares of Arcus Biosciences were trading at $22.81 as of May 05. Over the last 52-week period, shares are down 25.83%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Arcus Biosciences visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Preview: Precision BioSciences's Earnings
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Meridian Bioscience's Earnings: A Preview
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to…
Earnings Outlook For Selecta Biosciences
Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
Earnings Outlook For Coherus BioSciences
Coherus BioSciences (NASDAQ:CHRS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Aterian's Earnings Outlook
Aterian (NASDAQ:ATER) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know…
Earnings Outlook For Kaleyra
Kaleyra (AMEX:KLR) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know…
Get all your news in one place